Harm-benefit tradeoff of prostate-specific antigen screening was found to be more favorable with complementary approaches to quantifying overdiagnosis, compared with previous estimates that used shorter follow-up from the introduction of screening, ...
from Google Alert - health https://ift.tt/CIiTEYq
via IFTTT
0 comments:
Post a Comment